Cargando…

DNA damage repair mutations in pancreatic cancer– prognostic or predictive?

OBJECTIVE: The efficacy of platinum-based chemotherapy (PtCh) for pancreatic cancer (PC) patients with DNA damage repair gene mutations (DDRm) compared to those without DDRm remains uncertain. METHODS: After a thorough database searching in PubMed, Embase, and Web of Science, a total of 19 studies t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Ya-Fei, Hu, Hai-Jie, Kung, Heng-Chung, Lv, Tian-Run, Yu, Jun, Li, Fu-Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634423/ https://www.ncbi.nlm.nih.gov/pubmed/37954082 http://dx.doi.org/10.3389/fonc.2023.1267577

Ejemplares similares

Prognostic analysis of patients with breast cancer based on tumor mutational burden and DNA damage repair genes
por: Teng, Xu, et al.
Publicado: (2023)

Mutated DNA Damage Repair Pathways Are Prognostic and Chemosensitivity Markers for Resected Colorectal Cancer Liver Metastases
por: Wang, Kun, et al.
Publicado: (2021)

The consistencies and inconsistencies between distal cholangiocarcinoma and pancreatic ductal adenocarcinoma: A systematic review and meta-analysis
por: Lv, Tian-Run, et al.
Publicado: (2022)

A Prognostic DNA Damage Repair Genes Signature and Its Impact on Immune Cell Infiltration in Glioma
por: Wang, Guohui, et al.
Publicado: (2021)

Clinicopathological characteristics and outcome of primary sarcomatoid carcinoma of the gallbladder
por: Zou, Rui-Qi, et al.
Publicado: (2022)

DNA Damage, Repair, and Cancer Metabolism
por: Turgeon, Marc-Olivier, et al.
Publicado: (2018)

DNA Damage Repair Gene Mutations Are Indicative of a Favorable Prognosis in Colorectal Cancer Treated With Immune Checkpoint Inhibitors
por: Song, Yipeng, et al.
Publicado: (2021)

Prognostic Analysis of Differentially Expressed DNA Damage Repair Genes in Bladder Cancer
por: Yang, Yong, et al.
Publicado: (2022)

Comparison of clinicopathological characteristics and long-term survival between patients with gallbladder adenosquamous carcinoma and pure gallbladder adenocarcinoma after curative-intent surgery: a single-center experience in China and a meta-analysis
por: Lv, Tian-Run, et al.
Publicado: (2023)

Bibliometric analysis of single-cell sequencing researches on immune cells and their application of DNA damage repair in cancer immunotherapy
por: Zhao, Yu, et al.
Publicado: (2023)

ITGB5 promotes innate radiation resistance in pancreatic adenocarcinoma by promoting DNA damage repair and the MEK/ERK signaling pathway
por: Wen, Xin, et al.
Publicado: (2022)

Evaluation of circulating tumor DNA as a prognostic biomarker for metastatic pancreatic adenocarcinoma
por: Guan, Shasha, et al.
Publicado: (2022)

Reading, writing, and repair: the role of ubiquitin and the ubiquitin-like proteins in DNA damage signaling and repair
por: Pinder, Jordan B., et al.
Publicado: (2013)

DNA Damage Response and Repair Gene Alterations Increase Tumor Mutational Burden and Promote Poor Prognosis of Advanced Lung Cancer
por: Dai, Jiawei, et al.
Publicado: (2021)

Impact of DNA damage repair alterations on prostate cancer progression and metastasis
por: Lukashchuk, Natalia, et al.
Publicado: (2023)

ShaPINg Cell Fate Upon DNA Damage: Role of Pin1 Isomerase in DNA Damage-Induced Cell Death and Repair
por: Polonio-Vallon, Tilman, et al.
Publicado: (2014)

Connection between Tumor Suppressor BRCA1 and PTEN in Damaged DNA Repair
por: Minami, Akari, et al.
Publicado: (2014)

The Therapeutic Potential of DNA Damage Repair Pathways and Genomic Stability in Lung Cancer
por: Burgess, Joshua T., et al.
Publicado: (2020)

Targeting BRCA and DNA Damage Repair Genes in GI Cancers: Pathophysiology and Clinical Perspectives
por: Zimmer, Kai, et al.
Publicado: (2021)

Targeting DNA Damage Repair for Immune Checkpoint Inhibition: Mechanisms and Potential Clinical Applications
por: Sun, Wei, et al.
Publicado: (2021)

Editorial: Targeting DNA repair and the DNA damage response: Beyond the standard PI3 kinase-like kinases
por: Turchi, John J., et al.
Publicado: (2022)

RAD21 Confers Poor Prognosis and Affects Ovarian Cancer Sensitivity to Poly(ADP-Ribose)Polymerase Inhibitors Through DNA Damage Repair
por: Gou, Rui, et al.
Publicado: (2022)

A noninvasive nomogram model based on CT features to predict DNA mismatch repair deficiency in gastric cancer
por: Chen, Jie-Yu, et al.
Publicado: (2023)

Predictive and Prognostic Value of DNA Damage Response Associated Kinases in Solid Tumors
por: Gachechiladze, Mariam, et al.
Publicado: (2020)

Aberrant RON and MET Co-overexpression as Novel Prognostic Biomarkers of Shortened Patient Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Pancreatic Cancer
por: Hu, Chen-Yu, et al.
Publicado: (2019)

Bioinformatic analysis of FOXN3 expression and prognostic value in pancreatic cancer
por: Yu, Wei, et al.
Publicado: (2022)

Preventing Damage Limitation: Targeting DNA-PKcs and DNA Double-Strand Break Repair Pathways for Ovarian Cancer Therapy
por: Dungl, Daniela A., et al.
Publicado: (2015)

The Mutational Landscape of Pancreatic and Liver Cancers, as Represented by Circulating Tumor DNA
por: Rice, Alistair, et al.
Publicado: (2019)

A novel DNA damage repair-related signature for predicting prognositc and treatment response in non-small lung cancer
por: Li, Ling, et al.
Publicado: (2022)

GDPLichi: a DNA Damage Repair-Related Gene Classifier for Predicting Lung Adenocarcinoma Immune Checkpoint Inhibitors Response
por: Leng, Yang, et al.
Publicado: (2021)

Distinguishable Prognostic Signatures and Tumor Immunogenicity Between Pancreatic Head Cancer and Pancreatic Body/Tail Cancer
por: Ge, Weiyu, et al.
Publicado: (2022)

DNA methylation-based patterns for early diagnostic prediction and prognostic evaluation in colorectal cancer patients with high tumor mutation burden
por: Huang, Hao, et al.
Publicado: (2023)

A four oxidative stress gene prognostic model and integrated immunity-analysis in pancreatic adenocarcinoma
por: Wang, Hao, et al.
Publicado: (2023)

Early Detection in a Mouse Model of Pancreatic Cancer by Imaging DNA Damage Response Signaling
por: Knight, James C., et al.
Publicado: (2020)

The Prognostic Value of the DNA Repair Gene Signature in Head and Neck Squamous Cell Carcinoma
por: Ming, Ruijie, et al.
Publicado: (2021)

Construction of a DNA damage repair gene signature for predicting prognosis and immune response in breast cancer
por: Chang, Yiming, et al.
Publicado: (2023)

A clinical prognostic model for patients with esophageal squamous cell carcinoma based on circulating tumor DNA mutation features
por: Liu, Tao, et al.
Publicado: (2023)

The Epithelial to Mesenchymal Transition Related Gene Calumenin Is an Adverse Prognostic Factor of Bladder Cancer Correlated With Tumor Microenvironment Remodeling, Gene Mutation, and Ferroptosis
por: Du, YiHeng, et al.
Publicado: (2021)

A Lack of Effectiveness in the ATM-Orchestrated DNA Damage Response Contributes to the DNA Repair Defect of HPV-Positive Head and Neck Cancer Cells
por: Köcher, Sabrina, et al.
Publicado: (2022)

Radiomics Facilitates Candidate Selection for Irradiation Stents Among Patients With Unresectable Pancreatic Cancer
por: Zhou, Hai-Feng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cavap2o6t7erphdgv5i3f8e0ef